- Home
- RAPT vs GLRE Comparison
RAPT vs GLRE Comparison
Compare RAPT & GLRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RAPT | GLRE |
|---|---|---|
| Founded | 2015 | 2004 |
| Country | United States | Cayman Islands |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 498.4M | 459.3M |
| IPO Year | 2019 | 2007 |
Fundamental Metrics
Financial Performance| Metric | RAPT | GLRE |
|---|---|---|
| Price | $57.77 | $13.79 |
| Analyst Decision | Buy | |
| Analyst Count | 10 | 0 |
| Target Price | ★ $56.22 | N/A |
| AVG Volume (30 Days) | ★ 4.1M | 126.3K |
| Earning Date | 03-05-2026 | 03-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $661,540,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $5.67 | $11.57 |
| 52 Week High | $57.86 | $15.07 |
Technical Indicators
Market Signals| Indicator | RAPT | GLRE |
|---|---|---|
| Relative Strength Index (RSI) | 79.64 | 47.44 |
| Support Level | $57.61 | $13.89 |
| Resistance Level | $57.80 | $14.48 |
| Average True Range (ATR) | 0.12 | 0.27 |
| MACD | -0.22 | 0.04 |
| Stochastic Oscillator | 75.00 | 44.27 |
Price Performance
Historical ComparisonAbout RAPT RAPT Therapeutics Inc.
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.
About GLRE Greenlight Capital Re Ltd.
Greenlight Capital Re Ltd offers property and casualty reinsurance. Its customers are property and casualty insurers, and Greenlight takes on some of their risk in exchange for insurance premiums. It operates through one operating segment: property and casualty reinsurance. It generates revenue through premiums from reinsurance on property and casualty business assumed and income from investments.